% Expired Patents = 71.4

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 14

Loading Chart...

12 inventors (with patents filed for the assignee):

Kumaresh Soppimath (7 out of 61 patents)

Navneet Puri (7 out of 9 patents)

Satish K Pejaver (7 out of 12 patents)

4. Lakkaraju Dasaradhi (4 out of 6 patents)

5. Kanaiyalal R Patel (4 out of 4 patents)

6. Rama Sodum (4 out of 4 patents)

7. Hari Desu (4 out of 4 patents)

8. Tushar Hingorani (2 out of 32 patents)

9. Udaya Toti (1 out of 2 patents)

10. Shyamprasad Mukundan (1 out of 1 patent)

11. Sasank Chaitanya Kunadharaju (1 out of 1 patent)

12. Ketan Hippalgaonkar (1 out of 1 patent)

13. Navneet Puri (14 patents)

14. Tushar Malkan (0 patent)

15. Satish Pejaver (0 patent)

7 patents: Sort by Forward Citations

1. 10251891 - Aprepitant oral liquid formulations (2019-04-09),

2. 9968614 - Aprepitant injectable formulations (2018-05-15),

3. 9636376 - Stable compositions of peptide epoxy ketones (2017-05-02),

4. 9180093 - Stable bortezomib formulations (2015-11-10),

5. 9107821 - Stable bortezomib formulations (2015-08-18),

6. 9061037 - Stable bortezomib formulations (2015-06-23),

7. 8263578 - Stable bortezomib formulations (2012-09-11),

Innopharma, Inc. is a leading pharmaceutical company specializing in the development and manufacturing of innovative pharmaceutical products. With a focus on research and development, Innopharma strives to improve the quality of life for patients by delivering cutting-edge therapies across a range of therapeutic areas. Our state-of-the-art facilities and expert team of scientists and engineers ensure the highest standards of quality and efficacy in our products.

Profile summary based on public USPTO records.